Clinical Trial Update: Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

This clinical trial update compares the effects of valsartan versus perindopril on the HOMA-IR index in patients with chronic kidney disease in a Phase 4 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• VALSARTAN (Valsartan)
• perindopril (perindopril)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Chronic Kidney Disease | Phase 4 | Status: UNKNOWN